XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 406,436 $ 426,029
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 32,993 32,224
Deferred income taxes (1,967) 267
Depreciation 64,680 62,235
Amortization of intangibles 78,570 55,610
Realized gain on sale of investment 0 (651)
Change in operating assets and liabilities:    
Decrease in accounts receivable 27,457 100,327
Increase in inventories (2,032) (81,415)
Decrease (increase) in other current assets 1,279 (24,066)
Increase in other assets (18,416) (23,432)
Increase (decrease) in accounts payable and other current liabilities 36,485 (130,065)
Increase in deferred revenue and customer advances 37,972 38,959
Decrease in other liabilities (141,473) (83,335)
Net cash provided by operating activities 521,984 372,687
Cash flows from investing activities:    
Additions to property, plant, equipment and software capitalization (90,377) (119,044)
Business acquisitions, net of cash acquired 0 (1,285,907)
(Investments in) proceeds from unaffiliated companies (1,489) 651
Purchases of investments (2,796) (1,791)
Maturities and sales of investments 2,752 1,770
Net cash used in investing activities (91,910) (1,404,321)
Cash flows from financing activities:    
Proceeds from debt issuances 170,000 1,450,041
Payments on debt (700,000) (520,040)
Payments of debt issuance costs 0 (400)
Proceeds from stock plans 25,073 18,092
Purchases of treasury shares (13,475) (70,433)
Proceeds from derivative contracts 15,305 8,178
Net cash (used in) provided by financing activities (503,097) 885,438
Effect of exchange rate changes on cash and cash equivalents 8,461 2,081
Decrease in cash and cash equivalents (64,562) (144,115)
Cash and cash equivalents at beginning of period 395,076 480,529
Cash and cash equivalents at end of period $ 330,514 $ 336,414